64Cu DOTA-Trastuzumab PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 64Cu DOTA-Trastuzumab PET/CT, covering 2019-10-08 to 2019-10-08. Get the full timeline:
Most recent: Clinical Trial Update: 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer [NA]